Submitted by Anonymous (not verified) on 18 November 2025 - 15:35
Human medicines European public assessment report (EPAR): Oslif Breezhaler, indacaterol, Date of authorisation: 29/11/2009, Revision: 20, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Oslif Breezhaler, indacaterol, Date of authorisation: 29/11/2009, Revision: 20, Status: Authorised